Search alternatives:
significantly longer » significantly lower (Expand Search), significantly larger (Expand Search), significantly shorter (Expand Search)
treatment decreased » treatment increases (Expand Search)
longer decrease » larger decrease (Expand Search), linear decrease (Expand Search), largest decrease (Expand Search)
mean decrease » a decrease (Expand Search)
significantly longer » significantly lower (Expand Search), significantly larger (Expand Search), significantly shorter (Expand Search)
treatment decreased » treatment increases (Expand Search)
longer decrease » larger decrease (Expand Search), linear decrease (Expand Search), largest decrease (Expand Search)
mean decrease » a decrease (Expand Search)
-
121
-
122
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
123
-
124
-
125
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
126
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
127
-
128
-
129
B2 decreases glycolytic intermediates in cells.
Published 2025“…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …”
-
130
Regenerating axons are increased by ATRA and decreased by clodronate.
Published 2021“…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”
-
131
-
132
CNP decrease the number of cristae in melanoma cells.
Published 2020“…ANOVA with Dunnet´s post-hoc test was used for the determination of statistical significance among treatment groups. Data are means ± SEM, n = 3. ***, p < 0.0001.…”
-
133
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
134
-
135
-
136
-
137
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
138
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
139
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
140